Investigate the application protocol, feasibility, and efficacy of indocyanine green (ICG)-assisted near-infrared (NIR) fluorescence-guided resection in bone and soft tissue tumors. Assess the incidence of adverse events and evaluate the safety of the protocol.
Histologically confirmed diagnosis of bone and soft tissue tumors (according to the WHO Classification of Tumours of Soft Tissue and Bone, 4th Edition).
Medically fit to undergo surgical treatment based on preoperative evaluation.
Absence of cardiovascular, anesthesia-related, or other surgical contraindications.
Presence of severe or chronic kidney, liver, or pulmonary diseases.
Autonomous thyroid nodules or allergy to iodine/shellfish.
Deemed unable to tolerate surgery based on preoperative evaluation.